Patients with a poor outcome presented enhanced IDO1 activity and increased levels of KYN, KYNA, TGF-β and IL-6 in the early stage of sepsis, resulting in the development of endotoxin tolerance. The gene discussed is TGFB1; the disease is Sepsis.